Astra vaccine guidance will have negligible impact on rollout: England’s deputy chief medic

Palestinians get vaccinated against COVID-19 in Tubas

LONDON (Reuters) – Britain’s recommendation against giving the Oxford-AstraZeneca COVID-19 vaccine to those aged under 30 due to the risk of blood clots will have a negligible impact on the vaccine programme, England’s deputy chief medical officer Jonathan Van-Tam said.

“Because of our supply situation in relation to alternative vaccines, the effect on the timing of our overall programme should be zero or negligible,” he said at a briefing on Wednesday.

(Reporting by Guy Faulconbridge and Kate Holton, Writing by Paul Sandle; editing by James Davey)

More from our Sister Sites